Trupanion, Inc. (NASDAQ:TRUP) Receives $39.17 Average Price Target from Brokerages

Shares of Trupanion, Inc. (NASDAQ:TRUPGet Free Report) have received an average recommendation of “Hold” from the five ratings firms that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $39.17.

Several research firms have recently weighed in on TRUP. Evercore ISI lowered their price objective on Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday, February 20th. Piper Sandler lowered their price objective on Trupanion from $33.00 to $32.00 and set a “neutral” rating for the company in a research report on Friday, February 16th. Finally, Stifel Nicolaus lifted their price objective on Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a research report on Friday, February 16th.

Read Our Latest Analysis on TRUP

Trupanion Stock Up 6.6 %

Shares of NASDAQ:TRUP opened at $26.34 on Monday. The firm has a market cap of $1.10 billion, a P/E ratio of -24.39 and a beta of 1.72. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. Trupanion has a 12-month low of $18.45 and a 12-month high of $60.33. The business has a fifty day simple moving average of $27.82 and a 200 day simple moving average of $27.42.

Trupanion (NASDAQ:TRUPGet Free Report) last announced its earnings results on Thursday, February 15th. The financial services provider reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.13. The business had revenue of $295.50 million during the quarter, compared to analyst estimates of $289.84 million. Trupanion had a negative return on equity of 15.19% and a negative net margin of 4.03%. Trupanion’s revenue for the quarter was up 20.1% compared to the same quarter last year. During the same period last year, the company earned ($0.23) EPS. Analysts predict that Trupanion will post -0.43 earnings per share for the current year.

Institutional Trading of Trupanion

Large investors have recently made changes to their positions in the company. BluePath Capital Management LLC acquired a new position in Trupanion during the 3rd quarter valued at about $31,000. Belpointe Asset Management LLC boosted its stake in Trupanion by 2,500.0% during the 1st quarter. Belpointe Asset Management LLC now owns 832 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 800 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in Trupanion by 61.3% during the 2nd quarter. PNC Financial Services Group Inc. now owns 2,057 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 782 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in Trupanion by 128.4% during the 1st quarter. Tower Research Capital LLC TRC now owns 1,039 shares of the financial services provider’s stock valued at $45,000 after purchasing an additional 584 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its stake in Trupanion by 8,339.4% during the 2nd quarter. Russell Investments Group Ltd. now owns 2,785 shares of the financial services provider’s stock valued at $55,000 after purchasing an additional 2,752 shares during the last quarter.

About Trupanion

(Get Free Report

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Stories

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.